Data / Form D filings / CalciMedica, Inc.
CalciMedica, Inc.: Form D filings
CalciMedica, Inc., a biotechnology company in La Jolla, CA, filed 11 Form D notices with the SEC between 2011 and 2023. The latest, on April 4, 2023, reports $9.1 million sold of a $9.1 million offering to 55 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 COAST BOULEVARD SOUTH, SUITE 307, La Jolla, CA, 92037
- Phone
- (858) 952-5500
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1534133
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | New notice | $9,109,912 | $9,109,912 | 55 | Mar 20, 2023 | sec.gov | |
| Aug 15, 2019 | New notice | $79,999,992 | $54,999,994 | $24,999,998 | 8 | Jul 31, 2019 | sec.gov |
| Jun 13, 2018 | Amendment | $80,393,829 | $75,393,829 | $5,000,000 | 16 | Apr 29, 2016 | sec.gov |
| Jul 18, 2017 | Amendment | $45,393,828 | $32,943,696 | $12,450,132 | 16 | Apr 29, 2016 | sec.gov |
| May 13, 2016 | New notice | $45,393,828 | $20,943,699 | $24,450,129 | 15 | Apr 29, 2016 | sec.gov |
| Dec 21, 2015 | New notice | $1,000,000 | $750,000 | $250,000 | 1 | Dec 11, 2015 | sec.gov |
| Mar 6, 2015 | New notice | $1,740,000 | $1,740,000 | 2 | Feb 19, 2015 | sec.gov | |
| Oct 7, 2014 | New notice | $1,325,000 | $750,000 | $575,000 | 3 | Aug 21, 2014 | sec.gov |
| Oct 10, 2013 | Amendment | $2,000,000 | $1,455,000 | $545,000 | 7 | Sep 3, 2013 | sec.gov |
| Sep 18, 2013 | New notice | $2,000,000 | $1,205,000 | $795,000 | 6 | Sep 3, 2013 | sec.gov |
| Nov 8, 2011 | New notice | $1,000,000 | $610,000 | $390,000 | 7 | Oct 24, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric W. Roberts | Executive Officer, Director | |
| Daniel J. Geffken | Executive Officer | |
| A. Rachel Leheny | Executive Officer, Director | |
| Kenneth A. Stauderman | Executive Officer | |
| Sudarshan J. Hebbar | Executive Officer | |
| Eric N. Bjerkholt | Director | |
| Frederic N. Guerard | Director | |
| Robert N. Wilson | Director | |
| Fred N. Middleton | Director | |
| Michael J. Dunn | Executive Officer | |
| Allan N. Shaw | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CalciMedica, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.